Căutare | Mạng xã hội kotra-hanoi.org.vn

KUMUD SINGH a adăugat un fișier Health
2026-03-31 12:19:37 -

All Trans Retinoic Acid Market to Reach USD 780 Million by 2034 | CAGR 4.7%
According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034. All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...

0 Commentarii 0 Distribuiri 1496 Views

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
KUMUD SINGH a adăugat un fișier Health
2026-03-31 12:27:43 -

All Trans Retinoic Acid Market to Reach USD 780 Million by 2034 | CAGR 4.7%
According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034. All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...

0 Commentarii 0 Distribuiri 1493 Views

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
Karls Scott a adăugat un fișier Health
2026-04-30 06:10:41 -

Healthcare CRO Market Asia Pacific Growth Story
How Healthcare CRO Partners Are Redefining Clinical Development in 2026 The role of a Healthcare CRO has expanded far beyond outsourced project support. Today, contract research organizations are becoming strategic partners for pharmaceutical companies, biotechnology firms, and medical device innovators seeking faster, smarter, and more compliant development pathways. As healthcare innovation...

0 Commentarii 0 Distribuiri 110 Views

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
KUMUD SINGH a adăugat un fișier Health
2026-03-30 10:08:29 -

RdRp Inhibitor Market to Reach USD 521.68 Million by 2028 | CAGR 8.2%
According to a newly published market research report by 24LifeSciences, global RdRp inhibitor market was valued at USD 352.14 million in 2023 and is projected to reach USD 521.68 million by 2028, growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period 2024-2028. RNA-dependent RNA polymerase (RdRp) inhibitors represent a critical antiviral therapy class that prevents...

0 Commentarii 0 Distribuiri 948 Views

Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!